Endothelin, astrocytes and glaucoma

Experimental Eye Research

Volumn 93, Issue 2, 2011, Pages 170-177

  Prasanna, Ganesh ^a   Krishnamoorthy, Raghu ^a   Yorio, Thomas ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Astrocytes; Astrogliosis; Endothelin; Glaucoma; Neurodegeneration

Indexed keywords

CONNEXIN 43; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANIMALS; ASTROCYTES; ENDOTHELIN-1; GLAUCOMA; GLIOSIS; HUMANS; OPTIC NERVE DISEASES;

EID: 79959799743     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2010.09.006     Document Type: Article

References (92)

1. Baba A. Role of endothelin B receptors in reactive astrocytes. Life Sci. 1998, 62:1711-1715.
2. Belliveau D.J., Naus C.C. Cortical type 2 astrocytes are not dye coupled nor do they express the major gap junction genes found in the central nervous system. Glia 1994, 12(1):24-34.
3. Blomstrand F., Giaume C. Kinetics of endothelin-induced inhibition and glucose permeability of astrocyte gap junctions. J. Neurosci. Res. 2006, 83(6):996-1003. 1.
4. Bohm F., Pernow J., Lindstrom J., Ahlborg G. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men. Clin. Sci. (Lond) 2003, 104(2):143-151.
5. Buffo A., Rite I., Tripathi P., Lepier A., Colak D., Horn A.P., Mori T., Götz M. Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc. Natl. Acad. Sci. U S A. 2008, 105(9):3581-3586. 4.
6. Cattaruzza M., Dimigen C., Ehrenreich H., Hecker M. Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells. FASEB J. 2000, 14:991-998.
7. Castañeda M.M., Cubilla M.A., López-Vicchi M.M., Suburo A.M. Endothelinergic cells in the subependymal region of mice. Brain Res. 2010, 1321:20-30.
8. Cellini M., Possati G.L., Profazio V., Sbrocca M., Caramazza N., Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol. Scand. 1997, (Suppl. (224)):11-13.
9. Chauhan B.C., LeVatte T.L., Jollimore C.A., Yu P.K., Reitsamer H.A., Kelly M.E., Yu D.Y., Tremblay F., Archibald M.L. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol. Vis. Sci. 2004, 45(1):144-152.
10. Cronin M., Anderson P.N., Cook J.E., Green C.R., Becker D.L. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol. Cell Neurosci. 2008, 39(2):152-160.
11. Desai D., He S., Yorio T., Krishnamoorthy R.R., Prasanna G. Hypoxia augments TNF-alpha-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem. Biophys. Res. Commun. 2004, 318(3):642-648. 4.
12. Dibas A., Prasanna G., Yorio T. Localization of endothelin-converting enzyme in bovine optic nerve and retina. J. Ocul. Pharmacol. Ther. 2005, 21(4):288-297.
13. Ehrenreich H., Kehrl J.H., Anderson R.W., Rieckmann P., Vitkovic L., Coligan J.E., Fauci A.S. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res. 1991, 538:54-58.
14. Eng L.F., Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 1994, 4:229-237.
15. Escartin C., Bonvento G. Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 2008, 38(3):231-241.
16. Evans T., Deng D.X., Chen S., Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 2000, 49(4):662-666.
17. Frantseva M.V., Kokarovtseva L., Perez Velazquez J.L. Ischemia-induced brain damage depends on specific gap-junctional coupling. J. Cereb. Blood Flow Metab. 2002, 22(4):453-462.
18. Frantseva M.V., Kokarovtseva L., Naus C.G., Carlen P.L., MacFabe D., Perez Velazquez J.L. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J. Neurosci. 2002, 22(3):644-653.
19. Frisen J., Johansson C.B., Torok C., Risling M., Lendahl U. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J. Cell Biol. 1995, 131:453-464.
20. Gadea A., Schinelli S., Gallo V. Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 2008, 28(10):2394-2408.
21. Gajkowska B. Endothelin-like immunoreactivity in hippocampus following transient global cerebral ischemiaI. Neoronal and glial cells. Folia Neuropathologica 1997, 35:36-48.
22. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 2007, 13(2):54-63.
23. He S., Prasanna G., Yorio T. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest. Ophthalmol. Vis. Sci. 2007, 48(8):3737-3745.
24. Hernandez M.R., Miao H., Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog. Brain Res. 2008, 173:353-373.
25. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog. Retin. Eye Res. 2000, 19(3):297-321.
26. Herrero-González S., Valle-Casuso J.C., Sánchez-Alvarez R., Giaume C., Medina J.M., Tabernero A. Connexin43 is involved in the effect of endothelin-1 on astrocyte proliferation and glucose uptake. Glia 2009, 57(2):222-233. 15.
27. Hirsch E.C., Breidert T., Rousselet E., Hunot S., Hartmann A., Michel P.P. The role of glial reaction and inflammation in Parkinson's disease. Ann. NY Acad. Sci. 2003, 991:214-228.
28. Inman D.M., Horner P.J. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007, 55(9):942-953.
29. Iribarne M., Ogawa L., Torbidoni V., Dodds C.M., Dodds R.A., Suburo A.M. Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice. Am. J. Pathol. 2008, 172(4):1030-1042.
30. Ishikawa N., Takemura M., Koyama Y., Shigenaga Y., Okada T., Baba A. Endothelins promote activation of astrocytes in rat neostriatum through ETB receptors. Eur. J. Neurosci. 1997, 9:895-901.
31. Jiang M.H., Höög A., Ma K.C., Nie X.J., Olsson Y., Zhang W.W. Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport 1993, 4(7):935-937.
32. Johnson E.C., Deppmeier L.M., Wentzien S.K., Hsu I., Morrison J.C. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2000, 41(2):431-442.
33. Johnson E.C., Morrison J.C. Friend or foe? resolving the impact of glial responses in glaucoma. J. Glaucoma 2009, 18(5):341-353. (Review).
34. Källberg M.E., Brooks D.E., Garcia-Sanchez G.A., Komàromy A.M., Szabo N.J., Tian L. Endothelin 1 levels in the aqueous humor of dogs with glaucoma. J. Glaucoma 2002, 11(2):105-109.
35. Kalman M. Glial reaction and reactive glia. Non-neuronal Cells of the Nervous System: Function and Dysfunction 2004, 787-835. Elsevier, Amsterdam. L. Hertis (Ed.).
36. Kerr N.M., Johnson C.S., de Souza C.F., Chee K.S., Good W.R., Green C.R., Danesh-Meyer H.V. Immunolocalization of gap junction protein Connexin43 (GJA1) in the human retina and optic nerve. Invest. Ophthalmol. Vis. Sci. 2010, 51(8):4028-4034.
37. Koyama Y., Ishibashi T., Hayata K., Baba A. Endothelins modulate dibutyryl cAMP-induced stellation of cultured astrocytes. Brain Res. 1993, 600(1):81-88.
38. Koyama Y., Tsujkawa K., Matsuda T., Baba A. Intracerebroventricular administration of an endothelin ETB receptor agonist increases expressions of GDNF and BDNF in rat brain. Eur. J. Neurosci. 2003, 18(4):887-894.
39. Krishnamoorthy R.R., Rao V.R., Dauphin R., Prasanna G., Johnson C., Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can. J. Physiol. Pharmacol 2008, 86(6):380-393.
40. Lam D., Jim J., To E., Rasmussen C., Kaufman P.L., Matsubara J. Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates. Mol. Vis. 2009, 15:2217-2229.
41. Lazarini F., Strosberg A.D., Courad P.O., Cazaubon S.M. Coupling of ETB endothelin receptor to mitogen-activated protein kinase stimulation and DNA synthesis in primary culture of rat astrocytes. J. Neurochem. 1996, 66:459-465.
42. Lepple-Wienhues A., Becker M., Stahl F., Berweck S., Hensen J., Noske W., Eichhorn M., Wiederholt M. Endothelin-like immunoreactivity in the aqueous humor and in conditioned medium from cultures ciliary epithelial cells. Cur Eye Res. 1992, 11:1041-1046.
43. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Ståhlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28(3):468-481.
44. Liu B., Chen H., Johns T.G., Neufeld A.H. Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J. Neurosci. 2006, 26(28):7532-7540. 12.
45. Lütjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp. Eye Res. 2005, 81(1):1-4. (Review).
46. MacCumber M.W., Ross C.A., Snyder S.H. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. USA 1990, 87:2359-2363.
47. MacCumber M.W., Ross C.A., Glaser B.M., et al. Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. USA 1989, 86:7285-7289.
48. Malone P., Miao H., Parker A., Juarez S., Hernandez M.R. Pressure induces loss of gap junction communication and redistribution of connexin 43 in astrocytes. Glia 2007, 55(10):1085-1098. 1.
49. Miller R.H., Fulton B.P., Raff M.C. A novel type of glial cell associated with nodes of ranvier in rat optic nerve. Eur. J. Neurosci 1989, 1(2):172-180.
50. Minckler D.S., Spaeth G.L. Optic nerve damage in glaucoma. Surv. Ophthalmol. 1981, 26(3):128-148.
51. Mulligan S.J., MacVicar B.A. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004, 431(7005):195-199.
52. Murphy J.A., Archibald M.L., Chauhan B.C. The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation. Br. J. Ophthalmol 2010, 94(9):1233-1238.
53. Narayan S., Brun A.M., Yorio T. Endothelin-1 distribution and basolateral secretion in the retinal pigment epithelium. Exp. Eye Res. 2004, 79(1):11-19.
54. Nie X.J., Olsson Y. Endothelin peptides in brain diseases. Rev. Neurosci. 1996, 7:177-186.
55. Ostrow L.W., Sachs F. Mechanosensation and endothelin in astrocytes-hypothetical roles in CNS pathophysiology. Brain Res. Brain Res. Rev. 2005, 48(3):488-508. (Review).
56. Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wallén A., Perlmann T., Lendahl U., Betsholtz C., Berthold C.H., Frisén J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J. Cell Biol. 1999, 145(3):503-514.
57. Pena J.D., Taylor A.W., Ricard C.S., Vidal I., Hernandez M.R. Transforming growth factor beta isoforms in human optic nerve heads. Br. J. Ophthalmol. 1999, 83(2):132-133.
58. Peters C.M., Rogers S.D., Pomonis J.D., Egnaczyk G.F., Keyser C.P., Schmidt J.A., Ghilardi J.R., Maggio J.E., Mantyh P.W. Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injury-induced ischemia and gliosis. Exp. Neurol. 2003, 180(1):1-13. 2003 Mar, Erratum in: Exp Neurol. 182(2):518.
59. Prasanna G., Hulet C., Desai D., Krishnamoorthy R.R., Narayan S., Brun A.M., Suburo A.M., Yorio T. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol. Res. 2005, 51(1):41-50.
60. Prasanna G., Dibas A., Tao W., White K., Yorio T. Regulation of endothelin-1 in human non-pigmented ciliary epithelial cells by tumor necrosis factor-α. Exp. Eye Res. 1998, 66:9-18.
61. Prasanna G., Krishnamoorthy R., Clark A., Wordinger R.J., Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest. Ophthalmol. Vis. Sci. 2002, 43:2704-2713.
62. Radany E.H., Brenner M., Besnard F., Bigornia V., Bishop J.M., Deschepper C.F. Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes. Proc. Natl. Acad. Sci. U S A 1992, 89(14):6467-6471.
63. Rattner A., Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J. Neurosci. 2005, 25(18):4540-4549.
64. Ripodas A., deJuan J.A., Roldan-Pallares M., Bernal R., Moya J., Chao M., Lopez A., Fernandez-Cruz A., Fernandez-Durango R. Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res. 2001, 912:137-143.
65. Rogers S.D., Demaster E., Catton M., Ghilardi J.R., Levin L.A., Maggio J.E., Mantyh P.W. Expression of endothelin-B receptors by glia in vivo is increased after CNS injury in rats, rabbits, and humans. Exp. Neurol. 1997, 145(1):180-195.
66. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 2009, 80:224-232.
67. Rozyczka J., Figiel M., Engele J. Chronic endothelin exposure inhibits connexin43 expression in cultured cortical astroglia. J. Neurosci. Res. 2005, 79(3):303-309.
68. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 1994, 46:325-415.
69. Schinelli S. Pharmacology and physiopathology of the brain endothelin system: an overview. Curr. Med. Chem. 2006, 13(6):627-638. (Review).
70. Stokely M.E., Brady S.T., Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest. Ophthalmol. Vis. Sci. 2002, 43:3223-3230.
71. Sugiyama T., Moriya S., Oku H., Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv. Ophthalmol. 1995, 39(Suppl 1):S49-S56.
72. Surgucheva I., McMahan B., Ahmed F., Tomarev S., Wax M.B., Surguchov A. Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve. J. Neurosci. Res. 2002, 68(1):97-106.
73. Tansey M.G., Frank-Cannon T.C., McCoy M.K., Lee J.K., Martinez T.N., McAlpine F.E., Ruhn K.A., Tran T.A. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?. Front. Biosci. 2008, 13:709-717.
74. Teixeira A., Chaverot N., Strosberg A.D., Cazaubon S. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1. J. Neurochem. 2000, 74(3):1034-1040.
75. Tezel G., Li L.Y., Patil R.V., Wax M.B. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2001, 42:1787-1794.
76. Tezel G., Wax M.B. Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch. Ophthalmol. 2004, 122:1348-1356.
77. Tezel G., Luo C., Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest. Ophthalmol. Vis. Sci. 2007, 48(3):1201-1211.
78. Thanos S., Naskar R. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Exp. Eye Res. 2004, 79(1):119-129.
79. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res. 2008, 173:409-421.
80. Torbidoni V., Iribarne M., Suburo A.M. Endothelin receptors in light-induced retinal degeneration. Exp. Biol. Med. (Maywood). 2006, 231(6):1095-1100.
81. Wang L., Fortune B., Cull G., Dong J., Cioffi G.A. Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. Arch. Ophthalmol. 2006, 124(5):717-724.
82. Wang W., Redecker C., Yu Z.Y., Xie M.J., Tian D.S., Zhang L., Bu B.T., Witte O.W. Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition. J. Clin. Neurosci. 2008, 15(3):278-285.
83. Wang X., LeVatte T.L., Archibald M.L., Chauhan B.C. Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic experimental optic neuropathy. Exp. Eye Res. 2009, 88(3):378-385.
84. Wilhelmsson U., Li L., Pekna M., Berthold C.H., Blom S., Eliasson C., Renner O., Bushong E., Ellisman M., Morgan T.E., Pekny M. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J. Neurosci. 2004, 24(21):5016-5021. 26.
85. Wordinger R.J., Lambert W., Agarwal R., Liu X., Clark A.F. Cells of the human optic nerve head express glial cell line-derived neurotrophic factor (GDNF) and the GDNF receptor complex. Mol. Vis. 2003, 9:249-256. 16.
86. Yamashita K., Dirscher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin -1 gene by hypoxia contributions of hypoxia -induciblefactor-1, activated protein-1, GATA -2, and p300/CBP. J. Biol. Chem. 2001, 276:12645-12653.
87. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature 1988, 332:411-415.
88. Yang Z., Quigley H.A., Pease M.E., Yang Y., Qian J., Valenta D., Zack D.J. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest. Ophthalmol. Vis. Sci. 2007, 48(12):5539-5548.
89. Yorio T., Krishnamoorthy R., Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology?. J. Glaucoma 2002, 11(3):259-270. (Review).
90. Yuan L., Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000, 32:42-50.
91. Zhang W.W., Badonic T., Hoog A., Jiang M.H., Ma K.C., Nie X.J., Olsson Y. Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J. Neurol. Sci. 1994, 122:90-96.
92. Zode G.S., Clark A.F., Wordinger R.J. Activation of the BMP canonical signaling pathway in human optic nerve head tissue and isolated optic nerve head astrocytes and lamina cribosa cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:5058-5067.